Patient-specific variants of NFU1/NFU-1 disrupt cholinergic signaling in a model of multiple mitochondrial dysfunctions syndrome 1

• Peter A. Kropp,
• Philippa Rogers,
• Sydney E. Kelly,
• Rebecca McWhirter,
• Willow D. Goff,
• Ian M. Levitan,
• David M. Miller,
• Andy Golden

Affiliations

Peter A. Kropp

Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Philippa Rogers

Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Sydney E. Kelly

Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Rebecca McWhirter

Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37235, USA

Willow D. Goff

Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Ian M. Levitan

Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA

David M. Miller

Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37235, USA

Andy Golden

Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA